Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
2009 1
2010 1
2012 1
2015 1
2016 2
2017 1
2020 1
2021 4
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome.
He X, Findling JW, Auchus RJ. He X, et al. Pituitary. 2022 Jun;25(3):393-403. doi: 10.1007/s11102-022-01218-y. Epub 2022 Apr 26. Pituitary. 2022. PMID: 35471718 Free PMC article. Review.
PURPOSE: Literature regarding endogenous Cushing syndrome (CS) largely focuses on the challenges of diagnosis, subtyping, and treatment. ...METHODS: We review the literature on the pathogenesis of GWS and its clinical presentation. We provide strategie …
PURPOSE: Literature regarding endogenous Cushing syndrome (CS) largely focuses on the challenges of diagnosis, subtypin …
Approach to the Patient: Diagnosis of Cushing Syndrome.
Savas M, Mehta S, Agrawal N, van Rossum EFC, Feelders RA. Savas M, et al. J Clin Endocrinol Metab. 2022 Nov 23;107(11):3162-3174. doi: 10.1210/clinem/dgac492. J Clin Endocrinol Metab. 2022. PMID: 36036941 Free PMC article.
The pathogenesis includes administration of corticosteroids (exogenous Cushing syndrome) or autonomous cortisol overproduction, whether or not ACTH-dependent (endogenous Cushing syndrome). An early diagnosis of Cushing syndrome is warranted; however, in cl …
The pathogenesis includes administration of corticosteroids (exogenous Cushing syndrome) or autonomous cortisol overproduction, whether or n …
Cushing syndrome in pediatrics.
Stratakis CA. Stratakis CA. Endocrinol Metab Clin North Am. 2012 Dec;41(4):793-803. doi: 10.1016/j.ecl.2012.08.002. Epub 2012 Sep 27. Endocrinol Metab Clin North Am. 2012. PMID: 23099271 Free PMC article. Review.
This article presents the causes and discusses the treatment of endogenous Cushing syndrome. It also discusses the clinical and molecular genetics of inherited forms of this syndrome. ...
This article presents the causes and discusses the treatment of endogenous Cushing syndrome. It also discusses the c …
Adrenally Directed Medical Therapies for Cushing Syndrome.
Tritos NA. Tritos NA. J Clin Endocrinol Metab. 2021 Jan 1;106(1):16-25. doi: 10.1210/clinem/dgaa778. J Clin Endocrinol Metab. 2021. PMID: 33118025 Review.
CONTEXT: Endogenous Cushing syndrome (CS) is characterized by excess cortisol secretion, which is driven by tumorous secretion of corticotropin in the majority of patients. ...
CONTEXT: Endogenous Cushing syndrome (CS) is characterized by excess cortisol secretion, which is driven by tumorous se …
Cushing Syndrome Associated Myopathy: It Is Time for a Change.
Reincke M. Reincke M. Endocrinol Metab (Seoul). 2021 Jun;36(3):564-571. doi: 10.3803/EnM.2021.1069. Epub 2021 Jun 18. Endocrinol Metab (Seoul). 2021. PMID: 34139801 Free PMC article.
Cushing syndrome is the result of excessive levels of glucocorticoids. Endogenous Cushing syndrome is rare with an incidence of two to three cases per million per year. ...Growth hormone therapy in individuals with impaired growth hormone secretion could be a …
Cushing syndrome is the result of excessive levels of glucocorticoids. Endogenous Cushing syndrome is rare with an inci …
Effects of Glucocorticoids on Bone: What we can Learn from Pediatric Endogenous Cushing's Syndrome.
Tack LJ, Tatsi C, Stratakis CA, Lodish MB. Tack LJ, et al. Horm Metab Res. 2016 Nov;48(11):764-770. doi: 10.1055/s-0042-117721. Epub 2016 Oct 11. Horm Metab Res. 2016. PMID: 27728929 Review.
Investigation into the effects of GC exposure on the bone in endogenous Cushing syndrome have contributed to our understanding of bone microarchitecture, growth, healing, and regeneration. ...
Investigation into the effects of GC exposure on the bone in endogenous Cushing syndrome have contributed to our unders …
Factitious Cushing syndrome.
Cizza G, Nieman LK, Doppman JL, Passaro MD, Czerwiec FS, Chrousos GP, Cutler GB Jr. Cizza G, et al. J Clin Endocrinol Metab. 1996 Oct;81(10):3573-7. doi: 10.1210/jcem.81.10.8855803. J Clin Endocrinol Metab. 1996. PMID: 8855803
There have been few reports of factitious Cushing syndrome. To characterize the clinical and laboratory features leading to this unusual diagnosis, we describe 6 patients (5 women, 1 man), ages 31-44, identified retrospectively among 860 patients evaluated for hypercortiso …
There have been few reports of factitious Cushing syndrome. To characterize the clinical and laboratory features leading to this unus …
ASSOCIATION BETWEEN MIFEPRISTONE DOSE, EFFICACY, AND TOLERABILITY IN PATIENTS WITH CUSHING SYNDROME.
Yuen KC, Williams G, Kushner H, Nguyen D. Yuen KC, et al. Endocr Pract. 2015 Oct;21(10):1087-92. doi: 10.4158/EP15760.OR. Epub 2015 Jun 29. Endocr Pract. 2015. PMID: 26121447 Clinical Trial.
OBJECTIVE: To examine the relationship between dose, clinical response (based on independent evaluation of metabolic, physical, neurologic, and social assessments), and safety of mifepristone treatment in patients with endogenous Cushing syndrome (CS). …
OBJECTIVE: To examine the relationship between dose, clinical response (based on independent evaluation of metabolic, physical, neuro …
Posterior subcapsular cataract in endogenous Cushing syndrome: an uncommon manifestation.
Bouzas EA, Mastorakos G, Friedman TC, Scott MH, Chrousos GP, Kaiser-Kupfer MI. Bouzas EA, et al. Invest Ophthalmol Vis Sci. 1993 Dec;34(13):3497-500. Invest Ophthalmol Vis Sci. 1993. PMID: 8258505
The purpose of this study was to examine the effect of chronic endogenous hypercortisolism (endogenous Cushing syndrome) on the human lens. METHODS: Sixty consecutive patients (8 to 67 years of age, 46 females, 14 males) with endogenous Cushing …
The purpose of this study was to examine the effect of chronic endogenous hypercortisolism (endogenous Cushing syndrome …
Circadian Plasma Cortisol Measurements Reflect Severity of Hypercortisolemia in Children with Different Etiologies of Endogenous Cushing Syndrome.
Tirosh A, Lodish MB, Lyssikatos C, Belyavskaya E, Papadakis GZ, Stratakis CA. Tirosh A, et al. Horm Res Paediatr. 2017;87(5):295-300. doi: 10.1159/000464463. Epub 2017 Apr 21. Horm Res Paediatr. 2017. PMID: 28433999 Free PMC article. Clinical Trial.
BACKGROUND: The utility of circadian cortisol variation in estimating the degree of hypercortisolemia in different forms of endogenous Cushing syndrome (CS) has not been evaluated in children yet. ...
BACKGROUND: The utility of circadian cortisol variation in estimating the degree of hypercortisolemia in different forms of endogenous …
15 results